Alpha GPC: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Add standard page header banner for consistent formatting) |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{PageHeader|type=Ingredient · Medicinal}} | |||
L-alpha-glycerylphosphorylcholine. | L-alpha-glycerylphosphorylcholine. | ||
| Line 5: | Line 7: | ||
UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated. | UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated. | ||
UPDATE: As of May 2026, it has passed the safety assessment by EFSA [ | UPDATE: As of May 2026, it has passed the safety assessment by EFSA [https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2026.10008] | ||
It will now go to the EC for final approval as a Novel Food. | |||
[[Category:Ingredients]] | [[Category:Ingredients]] | ||
[[Category:Medicinal]] | [[Category:Medicinal]] | ||
Latest revision as of 13:42, 18 September 2026
Ingredient · Medicinal
Alpha GPC
G&G Cloud staff reference · last edited 18/09/2026
L-alpha-glycerylphosphorylcholine.
Commonly requested in sport and nootropic products. This is likely medicinal according to the HFMA.
UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated.
UPDATE: As of May 2026, it has passed the safety assessment by EFSA [1]
It will now go to the EC for final approval as a Novel Food.